Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models

Xiaoming OuyangDepartment of Dermatology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

http://orcid.org/0000-0002-6632-3190

Ashley BarlingDepartment of Dermatology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Aletha LeschDepartment of Dermatology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Jeffrey W. TynerDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Division of Hematology and Medical Oncology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Gabrielle ChoonooDivision of Bioinformatics and Computational Biology, Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Christina ZhengDivision of Bioinformatics and Computational Biology, Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Sophia JengDivision of Bioinformatics and Computational Biology, Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Toni M. WestDepartment of Pharmacology, University of California at Davis, 451 Health Science Dr., Davis, California

Daniel ClayburghDepartment of Otolaryngology-Head and Neck Surgery, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Operative Care Division, Portland VA Health Care System, 3710 SW US Veterans Hospital Rd., Portland, Oregon

Sara A. CourtneidgeDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Knight Cancer Institute, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Shannon K. McWeeneyDivision of Bioinformatics and Computational Biology, Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon

Molly Kulesz-MartinDepartment of Dermatology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, Oregon;Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OregonCorrespondence[email protected].

show all

Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models

2018CBT11285-s05.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models

2018CBT11285-s05.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date